Yuhan Replaces Merck To Market Samsung’s Biosimilars In Korea

 
• By Jung Won Shin
  
Samsung Bioepis
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Business

More from Generics Bulletin